OrbusNeich
Hong Kong, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A medical device innovator focused on advanced stent systems for cardiovascular interventions.
Cardiovascular
Technology Platform
Specializes in stent design with proprietary bioabsorbable polymer and endothelial progenitor cell capture technologies.
Opportunities
Growth in emerging markets and through clinical data demonstrating superior long-term safety of its stent technology.
Risk Factors
Market saturation and intense price competition in the coronary stent segment, alongside regulatory hurdles.
Competitive Landscape
A specialized competitor in the mature but innovation-driven global stent market, dominated by a few large corporations.